Text
1. The plaintiff's claim is dismissed.
2. The costs of lawsuit shall be borne by the Plaintiff.
Reasons
1. Basic facts
A. On August 19, 199, the Plaintiff entered into the 1st insurance contract between the Defendant and the insured (hereinafter “the 1st insurance contract of this case”).
(2) The Defendant did not pay the premium after paying the premium based on the instant Type 1 insurance contract by January 2, 1999.
(3) The plaintiff processed the termination of the first insurance contract of this case, and accordingly the cancellation refund amount is KRW 15,020.
나. 제2보험계약 (1) 원고는 2000. 10. 27.경 피고와 사이에 피보험자를 피고로 하여 톡톡여성건강보험계약(이하, 이 사건 제2보험계약이라 한다)을 체결하였다.
(2) The Defendant did not pay the premium after paying the premium based on the instant secondary insurance contract by February 2, 2001.
(3) The plaintiff processed the termination of the second insurance contract of this case. Accordingly, the cancellation refund is KRW 13,888.
C. Around December 28, 2000, the Plaintiff entered into an known pension insurance contract with the Defendant (hereinafter “instant third insurance contract”) with the Defendant as the insured on December 28, 200.
(2) The Defendant did not pay the premium after paying the premium based on the instant Type 3 insurance contract until February 2001.
(3) The plaintiff processed the termination of the third insurance contract of this case. Accordingly, the cancellation refund is zero won.
On February 15, 2008, the Plaintiff transferred the amount of KRW 28,908 (=15,020 won) (=13,888 won) to the Defendant’s account, which was the sum of the cancellation money of the instant 1 and 2 insurance contracts (i.e., KRW 15,020).
E. (1) Around April 11, 2014, the Defendant: (a) received a diagnosis of bad faith from the Plaintiff on or around August 20, 2012 in detail known in B Hospital; (b) received a diagnosis of bad faith from the Plaintiff; and (c) received a diagnosis of bad faith from the Plaintiff.
9.2. On April 2, 2014, the Plaintiff asserted that he/she was subject to fluoral care and fluoral tissue tests, and claimed insurance proceeds, such as cancer treatment costs and cancer surgery costs.
(2) On April 11, 2014, the Defendant around December 8, 2012.